News - Vaccines


Current filters:


Popular Filters

101 to 125 of 260 results

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos


UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst


While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

Infectious disease treatments market driven by growth in middle-income to low-income countries


The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

Merger between Intercell and Vivalis planned to complete soon


French biotech firm Vivalis (Euronext: VLS) previously-announced acquisition of Intercell (ICEL.VI) in…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

India-developed rotavirus vaccine demonstrates strong efficacy


In a public-private partnership, the Indian government's Department of Biotechnology (DBT) and Bharat…

Asia-PacificBharat BiotechPharmaceuticalResearchROTAVACVaccines

Takeda to acquire Inviragen, gaining rights to promising vaccines


Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) has entered into a definitive agreement to…

DENVaxInviragenMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsVaccines

Leading Russian vaccines producer Petrovax acquired by Pharmstandard


Russian drugmaker Pharmstandard is to acquire Petrovax Pharm, one of the country's largest producers…

Abbott LaboratoriesMergers & AcquisitionsPetrovax FarmPharmaceuticalPharmstandardVaccines

Sanofi says pediatric vaccine Hexyon/Hexacima approved in Europe


The European Commission has approved French drug major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur's…

EuropeHexacimaHexyonMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Abbott Labs told it cannot acquire Russia's Petrovax Farm


The Russian government has imposed a ban on the sale of Petrovax Farm, one of Russia's leading vaccines…

Abbott LaboratoriesBiotechnologyMergers & AcquisitionsPetrovax FarmVaccines

Adult vaccines market controlled by GSK and Merck


The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

More collaboration needed to raise vaccination rates in developing nations, says analyst


More collaboration is needed between pharmaceuticals companies, public health organizations and governments…


Sanofi Pasteur MSD files for EU approval of "Quadrivalent" flu vaccine


Sanofi Pasteur MSD, the joint venture between French drug major Sanofi (Euronext: SAN) vaccines unit…

EuropeMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

GlaxoSmithKline cleared for $91M flu vaccine plant in USA; Gets CRL on Q-Plan H5N1


UK pharma giant GlaxoSmithKline (LSE: GSK) and The Texas A&M University System (TAMUS) say that the US…

GlaxoSmithKlineNorth AmericaPharmaceuticalProductionQ-Plan H5N1RegulationVaccines

GlaxoSmithKline and Abbott to start production in Ukraine


UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

Sinovac rockets on strong data for Enterovirus 71 vaccine


Chinese vaccines maker Sinovac Biotech Ltd. (Nasdaq: SVA) saw its shares leap 53% to $4.88 in morning…

Asia-PacificEnterovirus 71PharmaceuticalRegulationResearchSinovacVaccines

Astellas ends FLT3 deal with Ambit; reports on flu vaccine ASP7374


The US subsidiary of Japanese drug major Astellas Pharma (TYO: 4503) and USA-based privately held firm…

Ambit BiosciencesASP7374Astellas PharmaLicensingOncologyPharmaceuticalquizartinibResearchVaccines

Russian government to develop domestic production of vaccines


The Russian government is considering investing in the domestic production of vaccines, by building a…


FDA delays approval of Dynavax' Heplisav, issuing CRL


Dynavax Technologies ( Nasdaq: DVAX) saw its shares plunge as much as 38% to $1.84 in pre-market trading…

Anti-viralsBiotechnologyDynavax TechnologiesHeplisavNorth AmericaRegulationVaccines

CHMP recommends approval of Sanofi Pasteur's Hexyon/Hexacima 6-1 pediatric vaccine


CHMP recommends approval of Sanofi Pasteur's Hexyon/Hexacima 6-1 pediatric vaccine

EuropeHexacimaHexyonPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Sanofi eyes big plans for China


French pharmaceutical giant Sanofi (Euronext: SAN) plans to complete building a large plant for the production…

Asia-PacificPharmaceuticalProductionSanofiSanofi PasteurVaccines

Generex highlights pipeline potential of Antigen Express subsidiary


Canada-based Generex Biotechnology (OTC Bulletin Board: GNBT) last week provided an overview of the current…

AE37Anti-viralsAntigen ExpressBiotechnologyGenerex BiotechnologyOncologyPharmaceuticalResearchVaccines

GAVI Alliance funds vaccines for cervical cancer in developing countries


More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

101 to 125 of 260 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top